AVANOS MEDICAL, INC. AVNS Balance Sheet

Avanos medical, inc. (AVNS)

Balance Sheet / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Dec'13
ASSETS
Current Assets
Cash and cash equivalents
187	205	214	288	348	384	411	479	203	219	166	154	143	113	86	79	165	129	112	114	166	149	58	44
Restricted cash
-	-	-	-	-	-	-	51	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts receivable, net of allowances
159	163	157	124	135	150	151	189	199	203	194	184	181	188	189	195	206	224	204	200	226	233	192	203
Inventories
153	145	144	133	129	121	121	107	92	91	300	296	273	80	298	310	308	303	323	323	293	283	294	285
Prepaid expenses and other current assets
23	23	29	26	47	57	52	48	15	14	20	19	16	16	31	25	26	18	-	-	-	15	-	6
Assets held for sale
-	-	-	-	-	-	0	0	650	632	-	-	-	194	-	-	-	-	-	-	-	-	-	-
Current deferred income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	25	14	17	2	50	45
Total Current Assets
524	538	546	572	660	713	737	876	1,161	1,160	681	654	614	593	605	609	706	676	666	653	703	683	596	585
Property, Plant and Equipment, net
178	184	182	174	159	154	137	123	117	109	261	259	258	109	265	272	275	279	282	286	281	277	292	324
Operating Lease Right-of-Use Assets
59	64	64	67	54	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill
799	800	800	782	783	783	786	763	764	764	1,032	1,030	1,029	762	1,031	1,031	946	945	943	1,422	1,422	1,426	1,429	1,430
Other Intangible Assets, net
179	184	189	158	163	168	173	139	144	148	154	159	164	168	176	182	77	82	89	95	101	108	116	141
Deferred Tax Assets
11	16	12	13	6	6	6	10	11	7	16	16	15	8	12	12	11	14	-	-	-	17	-	-
Other Assets
10	11	12	15	6	7	3	3	3	4	3	3	3	3	3	3	2	2	25	28	27	2	15	2
Assets held for sale
-	-	-	-	-	-	-	-	-	-	-	-	-	426	-	-	-	-	0	0	0	2	-	0
TOTAL ASSETS
1,763	1,799	1,807	1,783	1,834	1,833	1,844	1,917	2,202	2,195	2,148	2,124	2,086	2,071	2,095	2,112	2,019	2,000	2,006	2,485	2,536	2,517	2,449	2,484
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities
Current portion of operating lease liabilities
14	14	14	14	11	-	0	0	0	39	-	-	-	0	-	-	-	-	0	0	3	3	10	2
Related party debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9
Trade accounts payable
73	83	94	99	148	169	159	176	194	171	172	184	179	160	166	168	181	163	179	200	192	168	118	118
Accrued expenses
101	114	108	72	77	94	106	175	128	144	146	137	130	138	144	136	128	152	147	123	145	183	148	180
Liabilities held for sale
-	-	-	-	-	-	0	0	37	33	-	-	-	25	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities
189	212	218	187	238	264	265	352	360	389	319	321	310	324	310	304	309	315	326	324	341	356	277	310
Long-Term Debt
248	248	247	247	247	247	247	247	542	541	580	579	579	579	589	624	578	578	585	585	631	622	-	0
Operating Lease Liabilities
58	62	62	65	57	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Tax Liabilities
-	-	0	0	4	4	1	1	18	17	36	36	36	35	63	63	23	23	-	-	-	27	-	-
Other Long-Term Liabilities
10	11	11	5	5	19	30	29	30	31	31	30	29	23	30	30	28	27	52	53	52	20	92	94
Liabilities held for sale
-	-	-	-	-	-	-	-	-	-	-	-	-	6	-	-	-	-	-	-	-	-	-	-
Total Liabilities
507	534	540	506	553	536	544	630	951	980	968	968	955	969	993	1,022	939	944	965	963	1,024	1,026	370	404
Commitments and Contingencies
-	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	-	0
Stockholders’ Equity
Preferred stock - $0.01 par value - authorized 20,000,000 shares, none issued
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0
Common stock - $0.01 par value - authorized 300,000,000 shares, 47,755,911 outstanding as of March 31, 2020 and 47,734,206 outstanding as of December 31, 2019
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0
Additional paid-in capital
1,596	1,593	1,592	1,586	1,582	1,578	1,575	1,567	1,557	1,550	1,547	1,543	1,538	1,533	1,530	1,527	1,521	1,518	1,517	1,514	1,507	1,502	-	0
Kimberly-Clarks net investment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,100	2,098
Accumulated deficit
-284	-288	-282	-270	-262	-242	-240	-244	-279	-299	-332	-349	-366	-379	-389	-398	-404	-419	-433	36	29	7	-	0
Treasury stock
8	8	8	8	7	5	5	5	4	4	3	3	1	1	1	1	1	1	1	1	-	0	-	-
Accumulated other comprehensive loss
-46	-32	-34	-31	-33	-33	-30	-32	-21	-31	-30	-34	-39	-50	-38	-38	-36	-43	-42	-28	-25	-19	-21	-19
Total Stockholders’ Equity
1,256	1,265	1,266	1,276	1,280	1,297	1,300	1,286	1,251	1,215	1,180	1,156	1,130	1,102	1,101	1,089	1,079	1,055	1,041	1,521	1,511	1,491	2,079	2,079
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
1,763	1,799	1,807	1,783	1,834	1,833	1,844	1,917	2,202	2,195	2,148	2,124	2,086	2,071	2,095	2,112	2,019	2,000	2,006	2,485	2,536	2,517	2,449	2,484